BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36928568)

  • 21. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
    Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
    Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial decline in lung volume parameters on computed tomography (CT) predicts outcome in idiopathic pulmonary fibrosis (IPF).
    Robbie H; Wells AU; Fang C; Jacob J; Walsh SLF; Nair A; Camoras R; Desai SR; Devaraj A
    Eur Radiol; 2022 Apr; 32(4):2650-2660. PubMed ID: 34716781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
    Raghu G; van den Blink B; Hamblin MJ; Brown AW; Golden JA; Ho LA; Wijsenbeek MS; Vasakova M; Pesci A; Antin-Ozerkis DE; Meyer KC; Kreuter M; Santin-Janin H; Mulder GJ; Bartholmai B; Gupta R; Richeldi L
    JAMA; 2018 Jun; 319(22):2299-2307. PubMed ID: 29800034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry.
    Gao J; Kalafatis D; Carlson L; Pesonen IHA; Li CX; Wheelock Å; Magnusson JM; Sköld CM
    Respir Res; 2021 Feb; 22(1):40. PubMed ID: 33546682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serial automated quantitative CT analysis in idiopathic pulmonary fibrosis: functional correlations and comparison with changes in visual CT scores.
    Jacob J; Bartholmai BJ; Rajagopalan S; Kokosi M; Egashira R; Brun AL; Nair A; Walsh SLF; Karwoski R; Wells AU
    Eur Radiol; 2018 Mar; 28(3):1318-1327. PubMed ID: 28963678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated Quantitative Computed Tomography Versus Visual Computed Tomography Scoring in Idiopathic Pulmonary Fibrosis: Validation Against Pulmonary Function.
    Jacob J; Bartholmai BJ; Rajagopalan S; Kokosi M; Nair A; Karwoski R; Raghunath SM; Walsh SL; Wells AU; Hansell DM
    J Thorac Imaging; 2016 Sep; 31(5):304-11. PubMed ID: 27262146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical value of angiogenin in predicting the prognosis of patients with idiopathic pulmonary fibrosis].
    Bai Y; Zhu H; Sun Q; Gu G; Zhang L; Li Y; Yang B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):789-793. PubMed ID: 28936953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep Learning for Estimating Lung Capacity on Chest Radiographs Predicts Survival in Idiopathic Pulmonary Fibrosis.
    Kim H; Jin KN; Yoo SJ; Lee CH; Lee SM; Hong H; Witanto JN; Yoon SH
    Radiology; 2023 Mar; 306(3):e220292. PubMed ID: 36283113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostication of lung adenocarcinomas using CT-based deep learning of morphological and histopathological features: a retrospective dual-institutional study.
    Lee T; Lee KH; Lee JH; Park S; Kim YT; Goo JM; Kim H
    Eur Radiol; 2024 May; 34(5):3431-3443. PubMed ID: 37861801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of CT quantification in progressive fibrosing interstitial lung disease: a deep learning approach.
    Koh SY; Lee JH; Park H; Goo JM
    Eur Radiol; 2023 Dec; ():. PubMed ID: 38085286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between body fat decrease during the first year after diagnosis and the prognosis of idiopathic pulmonary fibrosis: CT-based body composition analysis.
    Lee JY; Yoon SH; Goo JM; Park J; Lee JH
    Respir Res; 2024 Feb; 25(1):103. PubMed ID: 38418966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of pulmonary function and usual interstitial pneumonia computed tomography patterns in idiopathic pulmonary fibrosis.
    Arcadu A; Byrne SC; Pirina P; Hartman TE; Bartholmai BJ; Moua T
    Respir Med; 2017 Aug; 129():152-157. PubMed ID: 28732823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of emphysema on physiological and prognostic characteristics of lung function in idiopathic pulmonary fibrosis.
    Yoon HY; Kim TH; Seo JB; Lee SM; Lim S; Lee HN; Kim N; Han M; Kim DS; Song JW
    Respirology; 2019 Jan; 24(1):55-62. PubMed ID: 30136753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
    Barisione G; Brusasco C; Garlaschi A; Baroffio M; Brusasco V
    J Appl Physiol (1985); 2016 May; 120(9):1029-38. PubMed ID: 26893034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis.
    Yoshikawa T; Otsuka M; Chiba H; Ikeda K; Mori Y; Umeda Y; Nishikiori H; Kuronuma K; Takahashi H
    BMC Pulm Med; 2020 Jan; 20(1):27. PubMed ID: 32005219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative CT analysis of honeycombing area in idiopathic pulmonary fibrosis: Correlations with pulmonary function tests.
    Nakagawa H; Nagatani Y; Takahashi M; Ogawa E; Tho NV; Ryujin Y; Nagao T; Nakano Y
    Eur J Radiol; 2016 Jan; 85(1):125-130. PubMed ID: 26724656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of mediastinal lymph node enlargement in chronic interstitial lung disease.
    Grecuccio S; Sverzellati N; Uslenghi E; Caminati A; Pedrazzi G; Zompatori M
    Diagn Interv Radiol; 2021 May; 27(3):329-335. PubMed ID: 34003121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibody status is not associated with change in lung function or survival in patients with idiopathic pulmonary fibrosis.
    Goobie GC; Ford-Sahibzada CA; Fritzler MJ; Johannson KA; Fell CD
    Respir Med; 2019 Jul; 153():85-90. PubMed ID: 31176275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis.
    Humphries SM; Mackintosh JA; Jo HE; Walsh SLF; Silva M; Calandriello L; Chapman S; Ellis S; Glaspole I; Goh N; Grainge C; Hopkins PMA; Keir GJ; Moodley Y; Reynolds PN; Walters EH; Baraghoshi D; Wells AU; Lynch DA; Corte TJ
    Respirology; 2022 Dec; 27(12):1045-1053. PubMed ID: 35875881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.